• Study of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Patients with Newly Diagnosed AL Amyloidosis with Heart Involvement

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Greece Italy The Netherlands Spain

  • Study on [68Ga]Ga-PentixaFor and [18F]FDG PET/CT Imaging for Staging Marginal Zone Lymphoma in Patients with Confirmed Diagnosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy Spain

  • Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Larotrectinib for Treating Children with Advanced Solid Tumors with NTRK Fusion

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Ireland Italy +3

  • Study on Dapagliflozin to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Poland

  • Study on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Poland Spain

  • Study of ALE.C04 and Pembrolizumab for Adults with Recurrent or Metastatic Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Italy Spain

  • Study on the Effect of Botulinum Toxin Type A and Physiological NaCl 0.9% in Patients with Piriformis Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on the Effects of GSK4004280 and GSK4011499 in Adults with HIV Infections

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain

  • Study on the Safety and Effectiveness of Telisotuzumab Vedotin for Patients with Previously Treated c-Met Positive Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Ireland Italy +2

powered by